• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Functional analysis of HELZ2 for nuclear receptor in vivo

Research Project

Project/Area Number 16H06668
Research Category

Grant-in-Aid for Research Activity Start-up

Allocation TypeSingle-year Grants
Research Field Metabolomics
Research InstitutionGunma University

Principal Investigator

YOSHINO SATOSHI  群馬大学, 医学部附属病院, 医員 (90786089)

Project Period (FY) 2016-08-26 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywords肥満 / 脂肪組織 / 核内受容体 / 転写因子 / PPARg / エピジェネティック / 糖尿病 / PPARg
Outline of Final Research Achievements

HELZ2 KO mice show the resistance for obesity and fatty liver. However, the function of HELZ 2 in adipose tissue (white adipose tissue, brown adipose tissue) is unknown, and functional analysis of HELZ2 in metabolic tissues was carried out in vivo.
In adipose tissue, the effect of the Pioglitazone was attenuated in KO mice. In addition, the expression levels of PPARg target genes ware not increased in Ko mice. In the acute cold exposure test, the body temperature was not decreased in KO mice compared with WT at acute cold exposure. In the mouse liver, it was confirmed that expression level of Helz2 gene was increased in the light phase period. In WAT, expression changes other than the light and dark periods were observed.

Report

(3 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Annual Research Report
  • Research Products

    (1 results)

All 2017

All Presentation (1 results)

  • [Presentation] PPARγの新規転写共役因子であるHELZ2ノックアウト(KO)マウスにおけるチアゾリジン系薬の効果の検討2017

    • Author(s)
      吉野 聡
    • Organizer
      第38回日本肥満学会
    • Related Report
      2017 Annual Research Report

URL: 

Published: 2016-09-02   Modified: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi